WELCOME
Welcome to the CME accredited satellite symposium Spotlight on Emerging Immunotherapy Approaches and MET Inhibitors in Advanced NSCLC, brought to you by Ology Medical Education. This educational event will include lively interactive panel presentations involving leading experts in NSCLC. The focus of this satellite symposium will be on the rationale and evidence for novel immunotherapy approaches and emerging MET inhibitors in overcoming present clinical challenges, and recent diagnostic advances for personalizing treatment strategies in patients with advanced NSCLC. Lunch will be provided.

EDUCATIONAL OBJECTIVES
By attending this satellite symposium attendees will be able to:

  • Summarize novel and emerging immunotherapy approaches and MET inhibitors, and evaluate their efficacy and safety in recent clinical trials
  • Discuss the potential role of these novel and emerging therapies in the treatment paradigm of patients with advanced NSCLC and the implications for clinical practice
  • Implement and assess new genomic profiling assays (e.g. liquid biopsy, NGS) that aid in identifying and treating patient subsets eligible for these novel and emerging therapies
  • Develop a care plan based on personalized treatment strategies to optimally manage patients receiving novel and emerging therapies, and to optimize the clinical utility of new diagnostic advances in detecting targetable mutations

TARGET AUDIENCE
This programme is intended for oncologists, pulmonologists, pathologists and respiratory physicians involved in the diagnosis, treatment, and management of patients with advanced NSCLC.

LANGUAGE
The official language of this satellite symposium is English.

SATELLITE VENUE
Room Hilton Head (1978), Hall 8.0 at Fira de Barcelona. Address: Gran Via Venue, Av. Joan Carles I, 64, 08908 L’Hospitalet de Llobregat, Barcelona, Spain

EDUCATIONAL PARTNER
Ology Medical Education
info@ologyeducation.org

This program was approved by the IASLC 2019 World Conference on Lung Cancer Program Committee as an independent activity held in conjunction with the IASLC 2019 World Conference on Lung Cancer. This program is not sponsored or endorsed by IASLC and is not part of the official IASLC accredited program.